-
公开(公告)号：US20240238351A1
公开(公告)日：2024-07-18
申请号：US18409857
申请日：2024-01-11
Applicant: Hyeon Jin KIM , SNJ PHARMA INC.
Inventor： Hyeon Jin KIM , Seong Tshool HONG , Jinny HONG , Mingda WANG , Enkhchimeg LKHAGVA , Su Ra KIM , Hae Mi KIM
Abstract: The present disclosure relates to gut microbes resistant against infectious diseases and uses thereof. More particularly, the present disclosure relates to microbes resistant against infectious diseases, which provide a preventive or therapeutic effect on infectious diseases caused by pathogenic microorganisms and relates to uses of the gut microbes. The gut microbes resistant are characterized in that they are selected from the group consisting of Oribacterium species JBO3-101 (accession number KACC 81250BP) and Ruminococcus species JBR5-501 (accession number KACC 81249BP). The gut microbes according to the present disclosure have the effect of rendering the host resistant to infectious diseases caused by pathogenic microorganisms when the microbes are ingested.
-
公开(公告)号：US20240358651A1
公开(公告)日：2024-10-31
申请号：US18553570
申请日：2022-03-30
Applicant: SNJ PHARMA INC
Inventor： Seong Tshool HONG , Hyeon Jin KIM , Jinny HONG , Chongkai ZHAI , Mingda WANG
CPC classification number: A61K9/5123 , A61K9/5192 , A61K45/06 , A61K47/28 , A61K47/6925
Abstract: The present invention relates to: oral nanoparticles for enabling oral administration of a bioactive compound which is typically administered by injection due to having low bioavailability attributable to issues with solubility, disintegration in the digestive tract, and intestinal permeability; a method of formulating the oral nanoparticles; and a use of the oral nanoparticles. In addition, the present invention relates to: oral nanoparticles capable of maintaining or protecting the balance in the gut microbiome by minimizing the exposure of the gut microbiome to a bioactive compound; a formulation; and a use of same.
-
Search Results
2
records
(took 0.022 seconds)
